Long-term flecainide therapy in type 3 long QT syndrome Article Swipe
Related Concepts
Ehud Chorin
,
Rivki Taub
,
Aharon Medina
,
Nir Flint
,
Sami Viskin
,
Jesaia Benhorin
·
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.1093/europace/euw439
· OA: W2593095413
YOU?
·
· 2017
· Open Access
·
· DOI: https://doi.org/10.1093/europace/euw439
· OA: W2593095413
These data suggest that long-term flecainide therapy is relatively safe and effective among LQT3 patients who carry the D1790G SCN5A mutation.
Related Topics
Finding more related topics…